Topline proof-of-concept data in vitiligo patients expected in 1H 2023 BRIDGEWATER, N.J., Nov. 17, 2022…
REHOVOT, Israel and WILMINGTON, Del., Nov. 17, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
As a certified partner, Linical will leverage Science 37’s Metasite™ to provide global access to patients…
BOTHELL, Wash., Nov. 17, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) today announced…
ZORYVE is now on formulary for one of the top pharmacy benefit managers serving commercially…
–Integration of technologies across proteomics, genetics, structural biology, chemistry, and bioinformatics enables advanced insights into…
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF OCTOBER 2022 VANCOUVER, BC, CANADA , Nov….
Phase 1 results showed that AV-101 was generally well tolerated with significantly reduced systemic exposure…
Company’s recent recruitment strategy change has resulted in an unprecedented level of inquiries regarding potential…
VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
EDIT-101 demonstrates a favorable safety profile across all dose cohorts Preliminary efficacy signals of consistent…
~ Event to be Webcast Live on uniQure’s Corporate Website at 8:30 a.m. EST ~…
Survey finds primary care providers wish patients would raise mental health concerns so they can provide…
EMERYVILLE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage…
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
-Broad partnership will strengthen Invivyd’s development platform and organizational capabilities towards acceleration of NVD200 clinical…
PRESS RELEASE FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV…
Interim clinical update on ACTengine® IMA203 TCR-T monotherapy targeting PRAME demonstrated high confirmed objective response…
– Collaboration will enable the development of investigational next-generation bispecific immunotherapies using CytomX’s Probody® and…
BGV co-leads €10 million seed investment in neuroscience company FundaMental Pharma Amsterdam, The Netherlands, 17…